U.S. Flow Cytometry Research Report 2024: A $2.61 Billion Market by 2030 Fueled by Increased Cancer Cases and Widespread Usage of Cutting-edge Flow Cytometry Technology - ResearchAndMarkets.com

The "U.S. Flow Cytometry Market Size, Share & Trends Analysis Report by Product (Software, Accessories), Technology (Cell-based, Bead-based), Application, End-use, Region, and Segment Forecasts, 2024-2030" report has been added to ResearchAndMarkets.com's offering.

The U.S. flow cytometry market size is anticipated to reach USD 2.61 billion by 2030 and is growing at a CAGR of 6.8% from 2024 to 2030

The market for flow cytometry is expanding faster in the U.S. owing to increased cancer cases and other chronic illnesses. According to the American Cancer Society (ACS), there were roughly 9,270 cancer deaths among adolescents and young adults in the U.S. in 2019 who were between the ages of 15 and 39, and there were about 89,500 new cases of cancer diagnosed in 2020. These factors would drive market growth.

The COVID-19 pandemic had a positive effect on the market. For instance, in August 2020, research published in Springer discovered that flow cytometry analysis of peripheral blood mononuclear cell (PBMC) phenotype helped to predict the risk of COVID-19 clinical progression and indicated that improved antigen presentation and more effective adaptive immune responses are associated with recovery from COVID-19. The increasing frequency of infectious and chronic disorders, most notably the COVID-19 outbreak, has increased the need for technology for study and diagnosis, supporting the market's growth.

Furthermore, the U.S. has a robust healthcare infrastructure, significant healthcare spending, and widespread usage of highly advanced flow cytometry technologies. In addition, owing to research universities engaging in a wide range of research activities and having developed pharmaceutical enterprises, there is an enormous need for flow cytometry workflow for research purposes. This results from the U.S.'s substantial investment in healthcare, highly developed healthcare infrastructure, and widespread usage of cutting-edge flow cytometry technology.

U.S. Flow Cytometry Market Report Highlights

• Based on product, instrument dominated the market and accounted for 35.08% in 2023. Flow cytometry instruments are crucial in clinical diagnostics for applications such as immunophenotyping cells to monitor HIV/AIDS progression, detect minimal residual disease in leukemia, and assess immune cell function, which will fuel the segment growth
• In terms of technology, the cell-based segment dominated the market share in 2023. This technology involves analyzing cells based on their characteristics, such as size, complexity, and the presence of specific molecules. On the other hand, the bead-based segment is expected to grow at the fastest CAGR over the forecast period
• Based on application, the clinical segment held the largest market share in 2023. The industrial segment is expected to grow fastest over the forecast period
• In terms of end-use, the academic institute segment held the largest market share in 2023. Clinical testing labs are anticipated to witness the fastest growth over the forecast period
• The U.S. is the major dominating country in the market due to the surging incidence rate of diseases such as cancer and HIV amongst the population in this country, which is boosting the demand for U.S. flow cytometry market
• In January 2024, Sony Biotechnology launched the EC800, a highly versatile flow cytometry analyzer. This innovative device caters to various applications, such as particle sizing, immunophenotyping, cell viability, absolute cell counting, and apoptosis detection, among others. The EC800 offers cost-effective solutions suitable for diverse research and diagnostic needs.

Company Profiles

• Sysmex Corp
• Becton, Dickinson, and Company (B.D.)
• Danaher Corp
• Thermo Fisher Scientific, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Sony Biotechnology, Inc.
• Beckman Coulter, Inc.
• Cytek Biosciences
• BioLegend, Inc.
• Enzo Biochem Inc.
• Cell Signaling Technology, Inc.
• NeoGenomics Laboratories
• Q2 Solutions (IQVIA)
• Elabscience Biotechnology Inc.
• Stratedigm, Inc.
• BioLegend, Inc.
• Union Biometrica, Inc.
• BennuBio Inc.
• ORLFO Technologies

Key Attributes:

Key Topics Covered:

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

2.1. Market Outlook

2.2. Segment Outlook

2.3. Competitive Insights

Chapter 3. U.S. Flow Cytometry Market Variables, Trends & Scope

3.1. Market Lineage Outlook

3.1.1. Parent Market Outlook

3.1.2. Related/ancillary Market Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.2. Market Restraint Analysis

3.3. U.S. Flow Cytometry Market Analysis Tools

3.3.1. Industry Analysis - Porter's

3.3.2. PESTEL Analysis

Chapter 4. U.S. Flow Cytometry Market: Product Estimates & Trend Analysis

4.1. Product Market Share, 2023 & 2030

4.2. Segment Dashboard

4.3. U.S. Flow Cytometry Market by Product Outlook

4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030

4.4.1. Instruments

4.4.1.1. Market Estimates and Forecasts 2018-2030 (USD Million)

4.4.1.2. Cell Analyzers

4.4.1.3. Cell Sorters

4.4.2. Reagents & Consumables

4.4.3. Software

4.4.4. Accessories

4.4.5. Services

Chapter 5. U.S. Flow Cytometry Market: Technology Estimates & Trend Analysis

5.1. Technology Market Share, 2023 & 2030

5.2. Segment Dashboard

5.3. U.S. Flow Cytometry Market by Technology Outlook

5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030

5.4.1. Cell-based

5.4.2. Bead-based

Chapter 6. U.S. Flow Cytometry Market: Application Estimates & Trend Analysis

6.1. Application Market Share, 2023 & 2030

6.2. Segment Dashboard

6.3. U.S. Flow Cytometry Market by Application Outlook

6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following

6.4.1. Research

6.4.1.1. Market Estimates and Forecasts 2018-2030 (USD Million)

6.4.1.2. Pharmaceutical

6.4.1.2.1. Market Estimates and Forecasts 2018-2030 (USD Million)

6.4.1.2.2. Drug Discovery

6.4.1.2.3. In Vitro Toxicity

6.4.1.2.4. Stem Cell

6.4.1.3. Apoptosis

6.4.1.4. Cell Sorting

6.4.1.5. Cell Cycle Analysis

6.4.1.6. Immunology

6.4.1.7. Cell Viability

6.4.2. Industrial

6.4.3. Clinical

6.4.3.1. Market Estimates and Forecasts 2018-2030 (USD Million)

6.4.3.2. Cancer

6.4.3.3. Organ Transplantation

6.4.3.4. Immunodeficiency

6.4.3.5. Hematology

6.4.3.6. Autoimmune Disorders

Chapter 7. U.S. Flow Cytometry Market: End-use Estimates & Trend Analysis

7.1. End-use Market Share, 2023 & 2030

7.2. Segment Dashboard

7.3. U.S. Flow Cytometry Market by End-use Outlook

7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030

7.4.1. Clinical Testing Labs

7.4.2. Academic Institutes

7.4.3. Commercial Organizations

7.4.3.2. Biotechnology Companies

7.4.3.3. Pharmaceutical Companies

7.4.3.4. CROs

7.4.4. Hospitals

Chapter 8. U.S. Flow Cytometry Market: Region Estimates & Trend Analysis

8.1. Regional Market Share, 2023 & 2030

8.2. U.S. Flow Cytometry Market by Regional Outlook

8.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030

8.3.1. West

8.3.2. Midwest

8.3.3. Northeast

8.3.4. Southwest

8.3.5. Southeast

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, by Key Market Participants

9.2. Company/Competition Categorization

9.3. Vendor Landscape

9.3.1. List of Key Distributors and Channel Partners

9.3.2. Key Customers

9.3.3. Key Company Heat Map Analysis, 2023

9.4. Company Profiles

9.4.1. Company Overview

9.4.2. Financial Performance

9.4.3. Product Benchmarking

9.4.4. Strategic Initiatives

For more information about this report visit https://www.researchandmarkets.com/r/xehtrt

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240711684265/en/